During the past decade, Shelby Research LLC conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Shelby Research LLC" are "Diffuse Cutaneous Systemic Sclerosis" (1 trials), "SLE; Drug" (1 trials) and "Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "Shelby Research LLC" in a lesser frequency.

Most popular intervention types in "Shelby Research LLC" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Afimetoran" (1 trials), "KPG-818 high dose" (1 trials), "KPG-818 low dose" (1 trials) and "KPG-818 mid dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shelby Research LLC" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Shelby Research LLC". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Shelby Research LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shelby Research LLC, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".